Condition
Breast Reconstruction Following Mastectomy
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting1
Completed1
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06013514Recruiting
Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
NCT05031962Active Not RecruitingPrimary
Safety and Clinical Performance of a Biological Matrix Used in Implant-based Breast Reconstruction
NCT04874402Not ApplicableWithdrawnPrimary
Prepectoral vs Partial Subpectoral Two-Stage Implant-Based Breast Reconstruction
NCT02775409Not ApplicableCompletedPrimary
Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction
Showing all 4 trials